Stephan Lab

Creating more effective methods to harness the antitumor activity of immune cells

July 2, 2018.  Fred Hutchinson Cancer Research Center highlights our recent publication in Cancer Research

June 12, 2018.  Dr. Fan Zhang, a postdoctoral fellow in our laboratory, was awarded a $100,000 postdoctoral fellowship by The American Brain Tumor Association to develop nanoparticles that can be used to reprogram tumor-infiltrating macrophages. 

Screen Shot 2018-06-12 at 5.10.22 PM.png
Screen Shot 2018-06-12 at 5.20.10 PM.png
 

December 21, 2017.  Nature Outlook covers our work on in situ-programming of tumor-specific T cells.

https://www.nature.com/magazine-assets/d41586-017-08701-8/d41586-017-08701-8.pdf

Screen Shot 2018-01-17 at 10.36.02 AM.png

 

 

August 30, 2017  Media coverage of our work to simplify CAR T-cell manufacturing using synthetic mRNA nanocarriers

http://rdcu.be/vpnP

fb_1200x630_NanoParicles.gif

November  29, 2016.  Geekwire, a national technology news site and radio show (geekwire.com) highlights the biopolymer implants developed by the Stephan group. Listen to the podcasts here:

 

 

September  21, 2016.  Fred Hutchinson Cancer Research Center features our work in immunobioengineering in the Fall 2016 Fall Advertising Campaign.

 The ad will run in the following publications

 -Washington DC Business Journal: 9/30

-USA Today- Future of Cancer Care Insert: 9/23

-Sunset Magazine- October Issue

-Wired and The New Yorker- November Issue

-Alaska Airlines magazine- December Issue

 

April 1, 2016. Prof. Stephan has been named the recipient of a 2016 Research Scholar Grant from the American Cancer Society. The Stephan lab will use this 4-year grant to develop injectable reagents that can quickly reprogram the patient’s immune cells (particularly T lymphocytes) to recognize and destroy tumors.

american-cancer-society-logo-0x200-c-center.png

 

May 22, 2015.  The Stephan lab’s research is highlighted on the Fred Hutchinson Cancer Research Center’s webpage: “The right tools for the job: taking immunotherapy to the next level”.

http://www.fredhutch.org/en/news/center-news/2015/05/taking-immunotherapy-to-next-level.html

 

      
  
 0 
 0 
 1 
 13 
 77 
 Fred Hutchinson Cancer Research Center 
 1 
 1 
 89 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
    
  
 0 
 0 
 1 
 13 
 78 
 Fred Hutchinson Cancer Research Center 
 1 
 1 
 90 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
     January 23, 2015.  Prof. Stephan receives the National Science Foundation CAREER Award.       

 

January 23, 2015.  Prof. Stephan receives the National Science Foundation CAREER Award. 

 

November 20, 2014.    The Stephan lab's first paper, entitled “Biopolymer implants enhance the efficacy of adoptive T cell therapy”, was accepted for publication by Nature Biotechnology.

http://www.nature.com/nbt/journal/v33/n1/full/nbt.3104.html

 

April 2, 2014.       Nature and Nature Biotechnology have invited  the Stephan lab to present their work at the 2014 Biotechnology International Organization (BIO) Convention in San Diego. The conference is entitled “Genomic Technologies and Biomaterials for Understanding Disease” and will be held at the San Diego Convention Center on June 23 and 24, 2014. 

 http://www.nature.com/natureconferences/gta/index.html

   
  
 Lucy Deckard 
 0 
 0 
 2010-04-08T03:06:00Z 
 2010-04-14T22:40:00Z 
 1 
 152 
 872 
 Fred Hutchinson Cancer Research Center 
 7 
 2 
 1022 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
    
  
 Lucy Deckard 
 0 
 0 
 2010-04-08T03:06:00Z 
 2010-04-14T22:40:00Z 
 1 
 149 
 853 
 Fred Hutchinson Cancer Research Center 
 7 
 1 
 1001 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
     March 12, 2014.      Dr. Stephan was elected to serve as Associate Scientific Advisors for  Science ’s sister journal,  Science Translational Medicine.         http://stm.sciencemag.org/site/ab  out/assoc_advisors.xhtml                   Science Translational Medicine invited members of the Advisory Board and principal investigators from Clinical and Translational Science Awards (CTSA) recipient institutions to nominate outstanding early-career translational scientists to serve as Associate Scientific Advisors for the journal. From this collection of nominees, the journal editors selected 26 Associate Advisors. With this program, Science Translational Medicine seeks to build connections with the community of trainees in translational medicine. In addition to acting as research advisors for Science Translational Medicine, these scientists will scan selected journals and choose and summarize research papers to be highlighted in the Editors' Choice section. Each Associate Advisor will have 8 to 10 of their articles appear in Science Translational Medicine over the next year.        
  
 Lucy Deckard 
 0 
 0 
 2010-04-08T03:06:00Z 
 2010-04-14T22:40:00Z 
 1 
 149 
 853 
 Fred Hutchinson Cancer Research Center 
 7 
 1 
 1001 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
     

March 12, 2014.      Dr. Stephan was elected to serve as Associate Scientific Advisors for Science’s sister journal, Science Translational Medicine.

 

http://stm.sciencemag.org/site/about/assoc_advisors.xhtml

 

 

 

Science Translational Medicine invited members of the Advisory Board and principal investigators from Clinical and Translational Science Awards (CTSA) recipient institutions to nominate outstanding early-career translational scientists to serve as Associate Scientific Advisors for the journal. From this collection of nominees, the journal editors selected 26 Associate Advisors. With this program, Science Translational Medicine seeks to build connections with the community of trainees in translational medicine. In addition to acting as research advisors for Science Translational Medicine, these scientists will scan selected journals and choose and summarize research papers to be highlighted in the Editors' Choice section. Each Associate Advisor will have 8 to 10 of their articles appear in Science Translational Medicine over the next year.

 

 

   
  
 0 
 0 
 1 
 70 
 404 
 Fred Hutchinson Cancer Research Center 
 3 
 1 
 473 
 14.0 
  
  
 
  
    
  
 Normal 
 0 
 
 
 
 
 false 
 false 
 false 
 
 EN-US 
 JA 
 X-NONE 
 
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
  
  
    
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
 
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
 
     November 7, 2013.    The Stephan lab was invited to present their work on biomaterial-supported T-cell implants at the Nature Scicafe event in San Francisco. This exclusive scientific forum that operates on an invitation-only basis and is hosted by the editors of Nature Biotechnology and Nature Medicine. This event provides the participating scientists with new connections and insight from the business audience regarding the potential commercialization of their work. 

November 7, 2013.    The Stephan lab was invited to present their work on biomaterial-supported T-cell implants at the Nature Scicafe event in San Francisco. This exclusive scientific forum that operates on an invitation-only basis and is hosted by the editors of Nature Biotechnology and Nature Medicine. This event provides the participating scientists with new connections and insight from the business audience regarding the potential commercialization of their work.